Relationship between blood lipid profiles and pancreatic islet [beta] cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study

Abstract

Doc number: 634

Abstract

Background: Dyslipidemia is present in people with diabetes as well as subjects with normal glucose tolerance (NGT). The purpose of this study was to investigate the relationship between lipid profiles and β cell function in Chinese individuals with NGT but without history of diabetes or prediabetes.

Methods: A total of 893 men and 1454 women aged 18-76 years living in Sichuan, China, who were not being treated with lipid-lowering drugs were enrolled in this study. Insulin sensitivity (IR) was evaluated using the homeostasis model assessment -IR (HOMA-IR), β-cell function was calculated by the following equation: ΔI30/ΔG30/ HOMA-IR (ΔI30/ΔG30: the ratio of incremental glucose and insulin 30 min after glucose intake). Multivariate linear regression analyses were performed to estimate the relationship between blood lipid and β cell function as standardized coefficients (β).

Results: β cell function decreased in men and women with increasing age. We found inverse relationships between β cell function and total cholesterol (TC) in men and women (β = -0.157 and -0.113, respectively, both p < 0.001), low-density lipoprotein-cholesterol (LDL-C; β = -0.130 and -0.068, respectively, both p < 0.001), TC/high-density lipoprotein-cholesterol (HDL-C) ratio (β = -0.084, p < 0.01 and -0.096, p < 0.001), and triglycerides (TG) (women only; β = -0.053, p < 0.05). However, β cell function was not associated with HDL-C in men or women (β = -0.034 and 0.000, respectively, both p > 0.05) or the TG/HDL-C ratio (β = -0.035 and -0.013, respectively, both p > 0.05). β cell function was significantly worse in males than in females in all age groups, except in subjects aged > 70 years.

Conclusions: Dyslipidemia is associated with dysfunction of pancreatic β cells in subjects with NGT and this is particularly evident in people with elevated TC and LDL-C levels, especially males.

Trial Registration Number: #TR-CCH-Chi CTR-CCH-00000361